National Microbiology Laboratory, Canada Report issue

Government Phase 1

Organization Overview

First Clinical Trial
2012
NCT01587131
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

National Microbiology Laboratory, Canada

Active Ingredients

Drugs in Phase 1 Trials (1)

fvh1 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 1)

Infections (Phase 1)

Influenza, Human (Phase 1)

Orthomyxoviridae Infections (Phase 1)

Respiratory Tract Diseases (Phase 1)

Respiratory Tract Infections (Phase 1)

RNA Virus Infections (Phase 1)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1